The opening of an office in Milan will enable PharmaLex to provide specialist support to the third largest pharmaceutical market in Europe
Tissue, Cell And Gene Therapy Development
Engage with global decision makers and influencers in the biotechnology hub of 2018! Meet us at the DIA Global Annual Meeting 2018 at booth #1126
Meet us at the BIO International Convention 2018 at booth #1309
Meet us at the DIA Europe 2018 meeting at booth #106
Meet us at booth #18 or listen to Wenda Brennan discuss the benefits of artificial intelligence on adverse event monitoring on 10-11 April in Washington D.C..
Arrange a meeting with our experts at the DIA Regulatory Submission, Information, and Document Management Forum on 5-7 February in North Bethesda, MD.
Meet our experts at booth #30 on the 22-24th January in Washington, DC.
Learn about M&A related Regulatory activities (Pre – and Post-Merger) and gain expert insights for successful execution of these activities
As foreseen in our last update, the future location of the European Medicines Agency (EMA) has now been announced.
The appointment of Laura Monkiene enhances the Regulatory Outsourcing Team and expands regulatory footprint, strengthening presence in the CIS region
The merger with TRAC Services will further consolidate our industry-leading team in the UK, strengthening our core services and bringing regional expansion in regulatory affairs
Last month, the European Medicines Agency (EMA) published its Brexit Preparedness Business Continuity Plan and has announced this week that it is getting ready for its relocation decision.
Temporary Authorization for Use (ATU) : How to get started?
The appointment of Adrian Pencak demonstrates PharmaLex’s commitment to strengthening its global sales organization
The partnership will enable the automation of summary documents using Artificial Intelligence based software
The new collaboration will use innovative AI technology to support PharmaLex’s pharmacovigilance solutions
Outsourcing can help fulfil a specific gap in expertise or manage an entire portfolio.
We are now able to offer our clients a real tax benefit.
Dr. Jones received an Honorary Lifetime Fellowship at the 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) on August 29, 2017 in Montreal, Canada